Toxicity is a common reason many drugs are pulled from market and new drug leads fail. Avoiding this outcome requires knowing when drugs are likely to cause toxicity.

As a step in this direction, University of Arkansas for Medical Sciences (UAMS) researcher Grover P. Miller, PhD, and collaborators have published a manuscript in the journal ACS Central Science describing their development of a model that predicts the reactivity of molecules toward biological molecules as possible causes underlying drug toxicity.

Bank of America continued its stalwart support for the University of Arkansas for Medical Sciences (UAMS) with a $24,500 corporate foundation gift given to the UAMS Center for Diversity Affairs at an August 23 presentation.